ZyVersa Therapeutics Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
Key Highlights: Closed business combination with Larkspur Health Acquisition Corp. in December 2022 and began trading on Nasdaq Global Market under the ticker symbol “ZVSA”Planning... | April 3, 2023
Source: marketscreener.com